Acesso livre
Acesso livre

Infectologia

Revisão | Calculando o custo neurológico da COVID-19.

19 Nov, 2021 | 13:15h

Counting the neurological cost of COVID-19 – Nature Reviews Neurology

 

Comentário no Twitter

 

Progresso global da tuberculose foi revertido pela pandemia de COVID-19.

19 Nov, 2021 | 13:14h

Global tuberculosis progress reversed by COVID-19 pandemic – The Lancet Respiratory Diseases

Conteúdos relacionados:

WHO Report: Tuberculosis deaths rise for the first time in more than a decade due to the COVID-19 pandemic.

How COVID is derailing the fight against HIV, TB and malaria.

How COVID hurt the fight against other dangerous diseases

World TB Day | Report: COVID-19 Eliminates Twelve Years of Progress Against Tuberculosis

WHO: Benefits of continuing to provide life-saving HIV services outweigh the risk of COVID-19 transmission by 100 to 1

Tuberculosis and Covid-19: Fighting a deadly syndemic

Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study

 

Comentário no Twitter

 

Perspectiva | O futuro da vacinação contra SARS-CoV-2 – Lições da Influenza.

19 Nov, 2021 | 13:12h

The Future of SARS-CoV-2 Vaccination — Lessons from Influenza – New England Journal of Medicine

Correlação entre o aumento de infecções por SARS-CoV-2 e o tempo de vacinação.

19 Nov, 2021 | 13:11h

Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine – Nature Communications

Comentário: Long-term effectiveness of Pfizer/BioNTech two-dose regimen mRNA vaccine – News Medical

China’s COVID vaccines have been crucial — now immunity is waning.

[Preprint] Breakthrough SARS-CoV-2 infections in 620,000 U.S. Veterans, February 1, 2021 to August 13, 2021 – “Vaccine protection declined by mid-August 2021, decreasing from 91.9% in March to 53.9%”.

Observational study in Qatar showed the effectiveness of Pfizer vaccine against any SARS-CoV-2 infection dropped to 20% in months 5 through 7 after the second dose, but effectiveness against severe Covid-19 remained high.

Cohort study: Pfizer vaccine effectiveness against any infections declined from 88% during the first month after full vaccination to 47% after 5 months. Vaccine effectiveness against hospital admissions remained high; 87% within 1 month, and 88% at 5 months after full vaccination, with no significant waning.

Editorial | Covid-19 vaccination: evidence of waning immunity is overstated.

COVID vaccine immunity is waning — how much does that matter? – “As debates about booster shots heat up, what’s known about the duration of vaccine-based immunity is still evolving”.

COVID vaccine effects wane over time but still prevent death and severe illness.

Perspective | What we actually know about waning immunity.

Another study shows Pfizer mRNA vaccine immunity is reduced over time.

[Press release – not published yet] Study shows vaccine protection wanes over time, but vaccines still offer good protection against severe disease.

Studies: COVID vaccine protection waning against infection but not hospitalization.

 

Comentário no Twitter

 

Opinião | Com 128 vacinas contra Covid em desenvolvimento clínico, não se sabe se as aprovadas/autorizadas são as melhores.

19 Nov, 2021 | 13:09h

With 128 Covid vaccines in clinical development, we don’t know if the approved/authorized ones are the best ones – STAT

M-A | Ferro por via intravenosa está associado com risco aumentado de infecção em comparação com ferro por via oral ou não reposição, o que deve ser equilibrado com os benefícios potenciais da redução na necessidade de transfusão sanguínea.

19 Nov, 2021 | 12:58h

Risk of Infection Associated With Administration of Intravenous Iron: A Systematic Review and Meta-analysis – JAMA Network Open

Comentário convidado: Intravenous Iron and Infection Risk—Still an Unanswered Question – JAMA Network Open

 

Comentário no Twitter

 

M-A | Efetividade das medidas de saúde pública na redução da incidência de Covid-19, na transmissão do SARS-CoV-2 e na mortalidade por Covid-19.

19 Nov, 2021 | 12:38h

Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis – The BMJ

 

Comentário no Twitter

 

Revisão | Crianças com menos de 12 anos deveriam ser vacinadas contra COVID-19?

19 Nov, 2021 | 12:37h

Should children be vaccinated against COVID-19? – Archives of Disease in Childhood

 

Comentário do autor no Twitter (fio – clique para saber mais)

 

Covid: no Reino Unido, crianças só devem tomar a dose da vacina 12 semanas depois de uma infecção.

19 Nov, 2021 | 12:35h

Covid: Children told to delay jab for 12 weeks after infection – BBC

Relatório original: Joint Committee on Vaccination and Immunisation (JCVI) advice on COVID-19 vaccination in people aged 16 to 17 years: 15 November 2021

Estudo observacional mostra que a efetividade de vacinas mRNA contra internação por Covid-19 entre adultos imunocomprometidos foi menor (77%) do que entre adultos imunocompetentes (90%).

19 Nov, 2021 | 12:33h

Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021 – CDC Morbidity and Mortality Weekly Report

Conteúdo relacionado: CDC Guidance: Immunocompromised may need a fourth Covid-19 shot.

 

Comentário no Twitter (fio – clique para saber mais)

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.